Skip to main content

July 23, 2020

the Amplified Sciences team, pictured L to R: Stephan Koenigsfest, Anuraag Yachamaneni, Fredrik Jansson-Knodell, Diana Caldwell, Vincent Jo Davisson and Ananya Sheth (photo courtesy of Purdue University)
the Amplified Sciences team, pictured L to R: Stephan Koenigsfest, Anuraag Yachamaneni, Fredrik Jansson-Knodell, Diana Caldwell, Vincent Jo Davisson and Ananya Sheth (photo courtesy of Purdue University)

WEST LAFAYETTE – A Purdue University-affiliated diagnostic startup will Friday take part in a national virtual investing event focused on healthcare startups. Amplified Sciences LLC, which specializes in detecting and pre-empting the risks of certain cancers, is one of five startups participating in MedCity INVEST.

The university says Amplified Sciences is working on advancing innovations for earlier detection of cancer and other diseases. The startup bases its products on patented technologies from Purdue and the laboratory of Vincent Jo Davisson.

“This is an incredible opportunity to be among a very select group of startups pitching technologies that are designed to save lives,” said Diana Caldwell, president of Amplified Sciences LLC.

In April, Amplified Sciences completed a $1.1 million seed funding round, with support from the Purdue Foundry Investment Fund.

“We eagerly anticipate tracking their progress going forward,” said John Hanak, managing director of Purdue Ventures. “The Foundry Investment Fund provides an important avenue for attracting interest in Purdue-affiliated life sciences companies like Amplified Sciences.”

Participating Indiana investors include Elevate Ventures, Gravity Ventures, IU Philanthropic Venture Fund, and Purdue Ventures. Investors from outside of Indiana including Houston Angel Network, St. Louis Arch Angels, and Golden Seeds, among others.

VIEW ARTICLE